The influence of 3TC resistance mutation M184I on the fidelity and error specificity of human immunodeficiency virus type 1 reverse transcriptase.

A common target for therapies against human immuno-deficiency virus type 1 (HIV-1) is the viral reverse transcriptase (RT). Treatment with the widely used nucleoside analog (-)-2', 3'-deoxy-3'-thiacytidine (3TC) leads to the development of resistance-conferring mutations at residue M184 within the Y...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	Nucleic Acids Res
Hauptverfasser:	Rezende, L F, Drosopoulos, W C, Prasad, V R
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Oxford University Press 1998
Schlagworte:	Research Article
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC147634/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9611256/ https://ncbi.nlm.nih.govhttps://doi.org/10.1093/nar/26.12.3066
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!